• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌细胞与免疫细胞之间的谷氨酰胺争夺战:揭示这场持续战斗的最新进展。

A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle.

机构信息

Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.

Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.

出版信息

J Exp Clin Cancer Res. 2024 Mar 8;43(1):74. doi: 10.1186/s13046-024-02994-0.

DOI:10.1186/s13046-024-02994-0
PMID:38459595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10921613/
Abstract

Glutamine metabolism plays a pivotal role in cancer progression, immune cell function, and the modulation of the tumor microenvironment. Dysregulated glutamine metabolism has been implicated in cancer development and immune responses, supported by mounting evidence. Cancer cells heavily rely on glutamine as a critical nutrient for survival and proliferation, while immune cells require glutamine for activation and proliferation during immune reactions. This metabolic competition creates a dynamic tug-of-war between cancer and immune cells. Targeting glutamine transporters and downstream enzymes involved in glutamine metabolism holds significant promise in enhancing anti-tumor immunity. A comprehensive understanding of the intricate molecular mechanisms underlying this interplay is crucial for developing innovative therapeutic approaches that improve anti-tumor immunity and patient outcomes. In this review, we provide a comprehensive overview of recent advances in unraveling the tug-of-war of glutamine metabolism between cancer and immune cells and explore potential applications of basic science discoveries in the clinical setting. Further investigations into the regulation of glutamine metabolism in cancer and immune cells are expected to yield valuable insights, paving the way for future therapeutic interventions.

摘要

谷氨酰胺代谢在癌症进展、免疫细胞功能和肿瘤微环境的调节中起着关键作用。越来越多的证据表明,代谢紊乱的谷氨酰胺与癌症的发生和免疫反应有关。癌细胞严重依赖谷氨酰胺作为生存和增殖的关键营养物质,而免疫细胞在免疫反应中需要谷氨酰胺来激活和增殖。这种代谢竞争在癌症和免疫细胞之间创造了一种动态的拉锯战。靶向谷氨酰胺转运体和下游参与谷氨酰胺代谢的酶具有很大的潜力,可以增强抗肿瘤免疫。全面了解这种相互作用背后复杂的分子机制对于开发创新的治疗方法、提高抗肿瘤免疫和改善患者预后至关重要。在这篇综述中,我们全面概述了最近在揭示癌症和免疫细胞之间谷氨酰胺代谢拉锯战方面的进展,并探讨了基础科学发现在临床环境中的潜在应用。进一步研究癌症和免疫细胞中谷氨酰胺代谢的调节有望产生有价值的见解,为未来的治疗干预铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/10921613/d69db026cbcb/13046_2024_2994_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/10921613/fc18e9abf46b/13046_2024_2994_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/10921613/785987d14beb/13046_2024_2994_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/10921613/df3a1775a20d/13046_2024_2994_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/10921613/8e6d7f32c538/13046_2024_2994_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/10921613/d69db026cbcb/13046_2024_2994_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/10921613/fc18e9abf46b/13046_2024_2994_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/10921613/785987d14beb/13046_2024_2994_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/10921613/df3a1775a20d/13046_2024_2994_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/10921613/8e6d7f32c538/13046_2024_2994_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa02/10921613/d69db026cbcb/13046_2024_2994_Fig5_HTML.jpg

相似文献

1
A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle.癌细胞与免疫细胞之间的谷氨酰胺争夺战:揭示这场持续战斗的最新进展。
J Exp Clin Cancer Res. 2024 Mar 8;43(1):74. doi: 10.1186/s13046-024-02994-0.
2
Exploiting pancreatic cancer metabolism: challenges and opportunities.挖掘胰腺癌代谢的潜力:挑战与机遇。
Trends Mol Med. 2024 Jun;30(6):592-604. doi: 10.1016/j.molmed.2024.03.008. Epub 2024 Apr 10.
3
Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis.与癌症发生和肿瘤微环境相关的谷氨酰胺代谢调节剂:泛癌症多组学分析。
Genes (Basel). 2021 Aug 25;12(9):1305. doi: 10.3390/genes12091305.
4
Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment.谷氨酰胺代谢的重编程及其对肿瘤微环境中免疫反应的影响。
Cell Commun Signal. 2022 Jul 27;20(1):114. doi: 10.1186/s12964-022-00909-0.
5
The potential therapeutic targets of glutamine metabolism in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中谷氨酰胺代谢的潜在治疗靶点。
Biomed Pharmacother. 2024 Jul;176:116906. doi: 10.1016/j.biopha.2024.116906. Epub 2024 Jun 14.
6
A glutamine 'tug-of-war': targets to manipulate glutamine metabolism for cancer immunotherapy.谷氨酰胺的“拉锯战”:用于癌症免疫治疗的调控谷氨酰胺代谢的靶点
Immunother Adv. 2021 Jun 1;1(1):ltab010. doi: 10.1093/immadv/ltab010. eCollection 2021 Jan.
7
Correction: A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle.更正:癌症与免疫细胞之间的谷氨酰胺拉锯战:揭示这场持续战斗的最新进展
J Exp Clin Cancer Res. 2024 Mar 26;43(1):93. doi: 10.1186/s13046-024-03018-7.
8
Targeting glutamine metabolism as a therapeutic strategy for cancer.针对谷氨酰胺代谢作为癌症治疗策略。
Exp Mol Med. 2023 Apr;55(4):706-715. doi: 10.1038/s12276-023-00971-9. Epub 2023 Apr 3.
9
Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the Convention.补充谷氨酰胺作为一种抗癌策略:一种有潜力的传统治疗替代方法。
Cancers (Basel). 2024 Mar 5;16(5):1057. doi: 10.3390/cancers16051057.
10
Advances in reprogramming of energy metabolism in tumor T cells.肿瘤 T 细胞能量代谢重编程的研究进展。
Front Immunol. 2024 Feb 13;15:1347181. doi: 10.3389/fimmu.2024.1347181. eCollection 2024.

引用本文的文献

1
Metabolic Reprogramming: A Crucial Contributor to Anticancer Drug Resistance.代谢重编程:抗癌药物耐药性的关键促成因素。
MedComm (2020). 2025 Sep 6;6(9):e70358. doi: 10.1002/mco2.70358. eCollection 2025 Sep.
2
Metabolic reprogramming and immunosenescence in colorectal cancer: mechanisms and therapeutic implications.结直肠癌中的代谢重编程与免疫衰老:机制及治疗意义
Front Cell Dev Biol. 2025 Aug 13;13:1662464. doi: 10.3389/fcell.2025.1662464. eCollection 2025.
3
Revolutionizing cancer treatment with Halomonas Aquamarina L-Glutaminase: insights from in vitro and computational studies.

本文引用的文献

1
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in mutant lung cancer.谷氨酰胺拮抗剂 DRP-104 抑制 突变肺癌的肿瘤生长并增强对检查点阻断的反应。
Sci Adv. 2024 Mar 29;10(13):eadm9859. doi: 10.1126/sciadv.adm9859. Epub 2024 Mar 27.
2
LncRNA Axis Contributes to Malignant Progression of Hepatocellular Carcinoma.长链非编码 RNA 轴促进肝细胞癌的恶性进展。
Discov Med. 2023 Dec;35(179):995-1014. doi: 10.24976/Discov.Med.202335179.96.
3
A PD-L1-targeting Regulator for Metabolic Reprogramming to Enhance Glutamine Inhibition-Mediated Synergistic Antitumor Metabolic and Immune Therapy.
利用嗜盐单胞菌L-谷氨酰胺酶革新癌症治疗:来自体外和计算研究的见解
Sci Rep. 2025 Aug 24;15(1):31086. doi: 10.1038/s41598-025-14230-6.
4
Glutaminase inhibition ameliorates cancer-associated fibroblast lipid support of pancreatic cancer cell growth.谷氨酰胺酶抑制可改善癌症相关成纤维细胞对胰腺癌细胞生长的脂质支持。
Cancer Metab. 2025 Aug 20;13(1):38. doi: 10.1186/s40170-025-00389-z.
5
Immunometabolic Targets in CD8 T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma.肝细胞癌肿瘤微环境中CD8 T细胞的免疫代谢靶点
Liver Cancer. 2024 Nov 21;14(4):474-496. doi: 10.1159/000542578. eCollection 2025 Aug.
6
Integrated multi-omics analysis identifies SELENOP and PKMYT1 as immune-metabolic hub genes in breast cancer.综合多组学分析确定硒蛋白P和M期周期蛋白依赖性蛋白激酶1为乳腺癌中的免疫代谢枢纽基因。
Biochem Biophys Rep. 2025 Aug 6;43:102198. doi: 10.1016/j.bbrep.2025.102198. eCollection 2025 Sep.
7
Metabolic Profiling of Distinct -Mutant Esophageal Adenocarcinoma Models Reveals Different Bioenergetic Dependencies.不同突变型食管腺癌模型的代谢谱分析揭示了不同的生物能量依赖性。
Int J Mol Sci. 2025 Jul 17;26(14):6869. doi: 10.3390/ijms26146869.
8
The Role of Lactate in Immune Regulation: A Metabolic Rheostat via Transporters, Receptors, and Epigenetic Modifiers.乳酸在免疫调节中的作用:通过转运体、受体和表观遗传修饰因子的代谢调节器
Cells. 2025 Jul 17;14(14):1096. doi: 10.3390/cells14141096.
9
Amino acids shape the metabolic and immunologic landscape in the tumor immune microenvironment: from molecular mechanisms to therapeutic strategies.氨基酸塑造肿瘤免疫微环境中的代谢和免疫格局:从分子机制到治疗策略。
Cancer Biol Med. 2025 Jul 24;22(7):726-46. doi: 10.20892/j.issn.2095-3941.2025.0115.
10
Glutamine-driven metabolic reprogramming promotes CAR-T cell function through mTOR-SREBP2 mediated HMGCS1 upregulation in ovarian cancer.谷氨酰胺驱动的代谢重编程通过mTOR-SREBP2介导的HMGCS1上调促进卵巢癌中CAR-T细胞的功能。
J Transl Med. 2025 Jul 17;23(1):803. doi: 10.1186/s12967-025-06853-0.
一种针对 PD-L1 的调节剂,用于代谢重编程以增强谷氨酰胺抑制介导的协同抗肿瘤代谢和免疫治疗。
Adv Mater. 2024 Feb;36(6):e2309094. doi: 10.1002/adma.202309094. Epub 2023 Dec 6.
4
Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity.氨基酸代谢重编程:为 T 细胞抗肿瘤免疫带来新的曙光。
J Exp Clin Cancer Res. 2023 Nov 3;42(1):291. doi: 10.1186/s13046-023-02845-4.
5
SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer.SLC38A5 促进乳腺癌中的谷氨酰胺代谢并抑制顺铂化疗敏感性。
Breast Cancer. 2024 Jan;31(1):96-104. doi: 10.1007/s12282-023-01516-8. Epub 2023 Nov 2.
6
SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer.SLC38A5 调节铁死亡以克服胰腺癌对吉西他滨的耐药性。
Cells. 2023 Oct 23;12(20):2509. doi: 10.3390/cells12202509.
7
Metabolic advantages of regulatory T cells dictated by cancer cells.癌细胞决定的调节性T细胞的代谢优势。
Int Immunol. 2024 Feb 14;36(2):75-86. doi: 10.1093/intimm/dxad035.
8
Spatially Resolved Metabolomics Combined with the 3D Tumor-Immune Cell Coculture Spheroid Highlights Metabolic Alterations during Antitumor Immune Response.空间分辨代谢组学联合 3D 肿瘤免疫细胞共培养球体突出了抗肿瘤免疫反应过程中的代谢变化。
Anal Chem. 2023 Oct 17;95(41):15153-15161. doi: 10.1021/acs.analchem.2c05734. Epub 2023 Oct 6.
9
Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer.靶向 SLC7A5 的谷氨酰胺代谢重编程增强了抗 PD-1 在三阴性乳腺癌中的疗效。
Front Immunol. 2023 Sep 4;14:1251643. doi: 10.3389/fimmu.2023.1251643. eCollection 2023.
10
System analysis based on glutamine catabolic-related enzymes identifies GPT2 as a novel immunotherapy target for lung adenocarcinoma.基于谷氨酰胺分解代谢相关酶的系统分析鉴定 GPT2 为肺腺癌的新型免疫治疗靶点。
Comput Biol Med. 2023 Oct;165:107415. doi: 10.1016/j.compbiomed.2023.107415. Epub 2023 Aug 29.